LASER 0174 LASER 0174 (Respaire-60 SR 200 mg / 60 mg)
Generic Name: guaifenesin/pseudoephedrine
Pill imprint LASER 0174 LASER 0174 has been identified as Respaire-60 SR 200 mg / 60 mg.
Respaire-60 SR is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Respaire-60 SR 200 mg / 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LASER 0174 LASER 0174
- 200 mg / 60 mg
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Laser Pharmaceuticals
More about Respaire-60 SR (guaifenesin / pseudoephedrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.